MLBA5: October / November 2008
Imugene's new vaccine promises greater protection against PRRS
A new vaccine from Imugene promises a "very high degree of protection" against PRRS.
Preliminary results from the company's recently completed trials in the US showed that the vaccine is particularly effective when two doses are administered either orally or by injection.
Results of the trials showed that vaccinated pigs challenged with the live PRRS virus had much lower lung lesion scores and better weight gains over the 14-day post-challenge period compared to the unvaccinated control pigs.
Intervet/Schering-Plough introduces Onset 5 IN vaccine for cattle
Intervet/Schering-Plough Animal Health has announced the availability of Onset 5 IN, the first intranasally-administered, five-way modified live virus (MLV) vaccine for healthy cattle 3-8 days and older.
Onset 5 IN is designed to stimulate at the site of infection an immune response to Bovine Virus Diarrhea (BVD) Type 1 and Type 2, Infectious Bovine Rhinotracheitis (IBR), Parainfluenza3 (PI3) and Bovine Respiratory Syncytial Virus (BRSV) - the costliest cattle diseases.
The vaccine is designed for use in both dairy and beef cattle, and is developed to address the immune challenges of newborns and animals under high stress, such as weaned calves and new arrivals post-transport.
The above are excerpts, full versions are only available in MEAT & LIVESTOCK Business Asia. For subscription enquiries, email membership@efeedlink.com |
Feed Grain
Back
